Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02686749 · ClinicalTrials.gov registry record · Phase 4
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT02686749 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 4 participants.
The verdict
NCT02686749, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is a multi-center, randomized, unblinded, clinical trial. The objective is to determine if catheter-based atrial fibrillation (AF) ablation is superior to medical treatment in patients with impaired left ventricular (LV) function who have been diagnosed with symptomatic AF within the past 12 months.
Interventions
- DEVICE Catheter Ablation
- DRUG FDA approved anti arrhythmic drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02686749
The ClinicalTrials.gov registry entry for NCT02686749 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Catheter Ablation is the first listed.
NCT02686749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02686749 about?
NCT02686749 is a clinical study titled "Catheter Ablation vs. Medical Therapy in Congested Hearts With AF". This study is a multi-center, randomized, unblinded, clinical trial. The objective is to determine if catheter-based atrial fibrillation (AF) ablation is superior to medical treatment in patients with impaired left ventricular (LV) function who have been diagnosed with symptomatic AF within the past...
What is the current status of trial NCT02686749?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2016-06. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT02686749?
The interventions under investigation include: Catheter Ablation (DEVICE), FDA approved anti arrhythmic drug (DRUG).
Who is sponsoring clinical trial NCT02686749?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.